
OPKO Health OPK
€ 0.98
-1.3%
Quartalsbericht 2025-Q2
hinzugefügt 31.07.2025
OPKO Health DSO 2011-2026 | OPK
DSO Jährlich OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 240 | 252 | 70.3 | 56.1 | 53.5 | 63.8 | 59.7 | 64 | 74.5 | 155 | 92.3 | 119 | 183 | 164 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 252 | 53.5 | 118 |
DSO Vierteljährlich OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.9 | 61.7 | 55.7 | 54.3 | 60.1 | 83.9 | 57.1 | 47.8 | - | 31.3 | 31.3 | 65.5 | 58.5 | 61.6 | 60.5 | 50.8 | 52.8 | 61 | 86.7 | 90.8 | 54.8 | 53.7 | 54.3 | 57.1 | 59.2 | 52.6 | 49.8 | 55.4 | 93.8 | 61.4 | 51.6 | 66.1 | 81.4 | 67.4 | 56.3 | 64.9 | 64 | 124 | 417 | 324 | 71.4 | 92.2 | 77.4 | 81.4 | 87.2 | 87.4 | 75.7 | 59.5 | 119 | 164 | 189 | 175 | 198 | 168 | 136 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 417 | 31.3 | 89.2 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Biodesix
BDSX
|
41.7 | $ 15.21 | 3.54 % | $ 1.97 B | ||
|
Bioventus
BVS
|
82.1 | $ 9.12 | 1.33 % | $ 608 M | ||
|
Biomerica
BMRA
|
57.7 | $ 2.12 | -0.47 % | $ 4.87 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 16.37 | 0.24 % | $ 495 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 75.01 | -0.96 % | $ 5.06 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 460.9 | 0.87 % | $ 13.3 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.77 | 2.36 % | $ 442 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.42 | -0.51 % | $ 390 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | ||
|
Pacific Biosciences of California
PACB
|
71.8 | $ 1.39 | -0.36 % | $ 417 M | ||
|
Co-Diagnostics
CODX
|
101 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Precipio
PRPO
|
28.1 | $ 26.85 | -0.3 % | $ 34.8 M | ||
|
Personalis
PSNL
|
55.8 | $ 7.7 | 1.18 % | $ 456 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
RadNet
RDNT
|
34.5 | $ 60.0 | -2.83 % | $ 4.51 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 159.79 | 1.13 % | $ 7.92 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 165.38 | -0.95 % | $ 28.4 B | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 6.74 | 1.81 % | $ 281 M | ||
|
Sotera Health Company
SHC
|
43.9 | $ 13.89 | 0.07 % | $ 3.94 B | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
63.7 | $ 1.24 | -15.07 % | $ 6.75 M | ||
|
Neuronetics
STIM
|
48.7 | $ 1.49 | -7.19 % | $ 98.3 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 256.48 | 1.41 % | $ 25.9 B | ||
|
Interpace Biosciences
IDXG
|
53.1 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
43.5 | $ 574.14 | -0.76 % | $ 46.2 B | ||
|
Illumina
ILMN
|
61.3 | $ 125.44 | 1.33 % | $ 19.9 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 101.04 | 0.68 % | $ 8.33 B | ||
|
Guardant Health
GH
|
46.1 | $ 85.0 | 0.05 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 45.99 | 3.35 % | $ 2.75 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 265.75 | 0.5 % | $ 22.1 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
7.11 | $ 3.36 | -3.45 % | $ 1.8 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 8.05 | -0.62 % | $ 1.03 B | ||
|
Natera
NTRA
|
81.5 | $ 195.23 | -2.43 % | $ 19.2 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 17.58 | 0.11 % | $ 937 M |